Pfizer has entered into a partnership with Laboratorio Teuto Brasileiro S.A., a Brazilian generics company, to develop and commercialize generic medicines. Pfizer will acquire a 40% stake in Teuto, expanding its presence in Brazil with access to Teuto’s portfolio of approximately 250 products. Pfizer will have access to distribution networks in Brazil and the opportunity to register and commercialize Teuto’s products in markets outside Brazil. Additionally, Pfizer will have two repre...